BUSCETI, Maria Teresa
 Distribuzione geografica
Continente #
NA - Nord America 151
EU - Europa 63
AS - Asia 36
Continente sconosciuto - Info sul continente non disponibili 1
Totale 251
Nazione #
US - Stati Uniti d'America 147
IT - Italia 35
SG - Singapore 27
DE - Germania 14
CN - Cina 5
CA - Canada 4
SE - Svezia 4
CZ - Repubblica Ceca 3
GB - Regno Unito 3
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
NL - Olanda 1
PK - Pakistan 1
PT - Portogallo 1
TR - Turchia 1
Totale 251
Città #
Chandler 32
Singapore 20
Santa Clara 12
Lawrence 9
Princeton 9
Milan 8
Redmond 4
London 3
Olomouc 3
Ottawa 3
Redwood City 3
Rome 3
Wilmington 3
Ashburn 2
Des Moines 2
Guangzhou 2
Norwalk 2
Rapallo 2
Settingiano 2
Acerra 1
Ankara 1
Beijing 1
Boardman 1
Calgary 1
Chicago 1
Dalian 1
Hong Kong 1
Karlsruhe 1
Mem Martins 1
Munich 1
Nagold 1
Padova 1
Sindelfingen 1
Vado Ligure 1
Vienna 1
Zaragoza 1
Totale 141
Nome #
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 39
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 33
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 32
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 27
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 26
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 25
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 24
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 23
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 20
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study 9
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 7
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 6
Totale 271
Categoria #
all - tutte 3.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.814


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 0 0 3 11
2020/202120 0 0 3 0 9 1 2 0 2 2 0 1
2021/202226 1 0 0 4 2 0 4 3 3 4 5 0
2022/2023104 18 4 10 1 12 10 2 9 19 9 6 4
2023/202432 6 4 6 4 1 4 0 0 0 0 5 2
2024/202567 17 1 1 1 15 23 2 2 4 0 1 0
Totale 271